Indian family businesses with strong cash flow are being sold by the next generation who prefer liquidity over continuing operations.
This trend occurs during a period of expanding domestic markets, diversifying global supply chains, and abundant capital in India.
Second and third-generation business families are choosing passive investments over building upon their parents' businesses.
Indian companies invest significantly less in Research and Development (R&D) compared to countries like China and South Korea.
The inherited elite in India, who control substantial capital, are opting out of risky and transformational building ventures, focusing instead on wealth preservation.
Detailed Insights:
Elite overproduction may explain risk retreat among incumbents, where surplus educated individuals lead to wealth preservation rather than conflict.
Capital is being recycled into assets that preserve wealth, such as real estate, financial markets, and established brands, rather than creating it.
Succession planning prioritizes maintaining control over expanding the family enterprise's frontier.
R&D investment is unattractive to second-generation families due to its need for patient capital, uncertain results, and potential for visible failures.
First-generation entrepreneurs like Dhirubhai Ambani took significant risks, contrasting with the risk-averse approach of the inherited elite.
The shift from 'culture' to 'civilisation' reflects a focus on administering and extracting value from existing assets rather than building foundational institutions.
India's dilemma lies in the inherited elite opting out of risky ventures, impacting the nation's economic trajectory over the next several decades.
Key Concepts Involved:
Liquidity: The availability of liquid assets to a company or market.
Elite Overproduction: A theory that societies become unstable when they produce more credentialed elite aspirants than available positions.
Research and Development (R&D): Activities undertaken to improve existing products and procedures, or to develop new products and procedures.